Isolation of Cells From Biopsy Tissue to Aid in Kidney Repair
NCT04896567 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2022-08-03
Summary
Endothelial progenitor cells that reside in renal vasculature may be stimulated to initiate differentiation programs during episodes of injury. It is hypothesized that endothelial progenitor cells resident in the kidney can transition to a post-injury phenotype that promotes endothelial repair.
Conditions
- Kidney Diseases
- Endothelial Dysfunction
Interventions
- DIAGNOSTIC_TEST
-
Cell isolation
Tissue from kidney biopsy will be used to isolate Cluster Differentiation 34+ cells.
Sponsors & Collaborators
-
Brigham and Women's Hospital
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-01-21
- Primary Completion
- 2023-12-30
- Completion
- 2024-12-30
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)
NCT02860130 ·Status: TERMINATED ·Phase: PHASE3
-
The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET Scan
NCT01238588 ·Status: TERMINATED ·Phase: NA
-
Long-Term Follow-up Study of Participants Exposed to Renal Autologous Cell Therapy Frozen Product
NCT06790498 ·Status: ENROLLING_BY_INVITATION
-
Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Allograft Nephropathy
NCT00659620 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Everolimus on CKD Progression in ADPKD Patients
NCT01009957 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5
NCT00616902 ·Status: TERMINATED ·Phase: PHASE3
-
Angiotensin II Blockade for Chronic Allograft Nephropathy
NCT00067990 ·Status: COMPLETED ·Phase: PHASE4
-
Mesenchymal Stem Cells for Chronic Kidney Diseases
NCT07240987 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Exercise Intolerance in Renal Failure
NCT01356966 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Lanabecestat in Participants With Severe Kidney Impairment Compared to Healthy Participants
NCT03545087 ·Status: WITHDRAWN ·Phase: PHASE1
-
Safety and Efficacy Study of Mesenchymal Stem Cell in Treating Kidney Fibrosis
NCT03460223 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Inflammation in Chronic Kidney Disease and Cardiovascular Disease - The Role of Genetics and Interleukin-1 Receptor Antagonist (IL-1ra)
NCT00897715 ·Status: COMPLETED ·Phase: PHASE2
-
Rituximab to Prevent Recurrence of Proteinuria
NCT01164098 ·Status: TERMINATED ·Phase: PHASE3
-
TARGTEPO Treatment for Anemia in End Stage Renal Disease (ESRD) Patients Undergoing Peritoneal Dialysis (PD)
NCT02378662 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of Renal Drug Transport in Healthy Volunteers
NCT00690014 ·Status: COMPLETED ·Phase: NA
-
Repository Study of Autosomal Dominant Polycystic Kidney Disease
NCT01988038 ·Status: WITHDRAWN
-
Fondaparinux as an Anticoagulant in Haemofiltration in Patients With Acute Kidney Failure.
NCT00256100 ·Status: TERMINATED ·Phase: NA
-
The Impact of Velcade(TM)on Antibody Secreting Cells in Sensitized Renal Allograft Candidates
NCT00722722 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial to Assess Efficacy and Safety of ex Vivo Allograft Admin of iCM012 Solution 2 mg/ml to Improve Its Function in Recipients of DCD Kidneys
NCT06582485 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
TARGTEPO Treatment for Anemia in Chronic Kidney Disease (CKD) Patients and End-Stage Renal Disease (ESRD)
NCT02117427 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney Disease
NCT06598631 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)
NCT02414841 ·Status: COMPLETED ·Phase: PHASE3
-
Targeting FMO-Mediated TMAO Formation in Kidney Disease (TMAO) Study
NCT03152097 ·Status: COMPLETED ·Phase: NA
-
A Study of PRT-201 Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-1)
NCT02110901 ·Status: COMPLETED ·Phase: PHASE3
-
Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
NCT04344769 ·Status: RECRUITING